Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial ResultsBusiness Wire • 10/22/26
Will Nerlynx Continue to Aid Puma Biotechnology's Top Line in Q3?Zacks Investment Research • 10/20/26
4 Breast Cancer Stocks to Watch During Breast Cancer Awareness MonthZacks Investment Research • 10/16/26
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 10/05/26
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer BeginsZacks Investment Research • 09/18/26
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung CancerBusiness Wire • 09/17/26
Puma Biotechnology to Present at H.C. Wainwright's 28th Annual Global Investment ConferenceBusiness Wire • 09/09/26
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/03/26
Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to DeclineZacks Investment Research • 07/30/26
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial ResultsBusiness Wire • 07/23/26
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial ResultsBusiness Wire • 04/23/26
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's WhyZacks Investment Research • 03/18/26